Effect of weight loss on the retinochoroidal structural alterations among patients with exogenous obesity.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 20 03 2020
accepted: 24 06 2020
entrez: 10 7 2020
pubmed: 10 7 2020
medline: 20 9 2020
Statut: epublish

Résumé

To evaluate the changes in the retinochoroidal vasculature in patients with exogenous obesity using swept-source optical coherence tomography (SS-OCT) and OCT angiography (OCTA). In this prospective study, 60 patients diagnosed with obesity (47 males) (mean age: 46.47±10.9 years) were included, of which 30 patients underwent bariatric surgery (Group A), and 30 patients underwent conservative management (exercise/diet) (Group B). Parameters including choroidal thickness (CT), choroidal vascularity index (CVI) and retinal capillary density index (CDI) and arteriovenous ratio (AVR) were measured at the baseline and three months follow up. 30 eyes (30 age and gender-matched) of normal participants were included for comparison. Baseline CT was lower in 60 participants with obesity compared to controls. Compared with normal subjects, subjects with obesity had higher mean CVI (0.66±0.02 versus 0.63±0.04; p<0.01), smaller FAZ area (0.26±0.07 versus 0.45±0.32; p<0.01), higher CDI (superficial plexus: 0.7±0.04 versus 0.68±0.06; p = 0.04, deep plexus: 0.38±0.02 versus 0.35±0.06; p = 0.01), and lower AVR (0.68±0.05 versus 0.70±0.03 versus; p<0.01). At 3-month after intervention, CT showed a significant increase in participants from Group A (329.27±79μm; p<0.01) but not in Group B from baseline. No significant change was noted in CVI or CDI at 3-month in either group compared to baseline. AVR significantly increased in Group B (p = 0.03). Subclinical changes in retinochoroidal vasculature occurs in participants with exogenous obesity compared to healthy subjects. Surgical intervention (bariatric surgery) may have a favorable outcome on the choroidal thickness in these patients.

Identifiants

pubmed: 32645116
doi: 10.1371/journal.pone.0235926
pii: PONE-D-20-08014
pmc: PMC7347179
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0235926

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Arch Surg. 2006 Mar;141(3):276-83
pubmed: 16549693
Invest Ophthalmol Vis Sci. 2015 Jan 08;56(2):705-10
pubmed: 25574054
PLoS One. 2014 Feb 24;9(2):e89923
pubmed: 24587127
Nat Rev Gastroenterol Hepatol. 2013 Oct;10(10):575-84
pubmed: 23835488
J Clin Epidemiol. 1991;44(6):545-50
pubmed: 2037859
Obesity (Silver Spring). 2012 Nov;20(11):2262-7
pubmed: 22555362
Metab Syndr Relat Disord. 2015 Dec;13(10):423-44
pubmed: 26569333
PLoS One. 2018 May 16;13(5):e0197457
pubmed: 29768485
Int Ophthalmol. 2015 Jun;35(3):403-10
pubmed: 24950905
Annu Rev Public Health. 2008;29:273-95
pubmed: 18173389
Microcirculation. 2010 Oct;17(7):495-503
pubmed: 21040115
Sci Rep. 2016 Feb 12;6:21090
pubmed: 26868048
Retina. 2016 Sep;36(9):1646-51
pubmed: 27124882
Exp Eye Res. 1999 Oct;69(4):413-29
pubmed: 10504275
Exp Clin Endocrinol Diabetes. 1997;105 Suppl 2:38-40
pubmed: 9288542
Curr Eye Res. 1995 Dec;14(12):1147-53
pubmed: 8974844
Eur Rev Med Pharmacol Sci. 2016 Mar;20(5):886-91
pubmed: 27010146
Arch Ophthalmol. 2003 Jun;121(6):785-92
pubmed: 12796248
Ophthalmic Surg Lasers Imaging Retina. 2017 Jan 1;48(1):10-17
pubmed: 28060389
Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3768-74
pubmed: 17652750
Int J Retina Vitreous. 2016 Nov 1;2:25
pubmed: 27847643
BMC Ophthalmol. 2016 May 04;16(1):48
pubmed: 27142207
Invest Ophthalmol Vis Sci. 1997 Aug;38(9):1752-60
pubmed: 9286263
Ophthalmology. 1999 Dec;106(12):2269-80
pubmed: 10599656
Prog Retin Eye Res. 2012 Sep;31(5):377-406
pubmed: 22580107
Retina. 2015 Oct;35(10):2085-90
pubmed: 25932552
SSM Popul Health. 2019 Feb 02;9:100372
pubmed: 31998823
Hypertension. 2012 Nov;60(5):1094-103
pubmed: 23045470
Invest Ophthalmol Vis Sci. 2012 Jan 25;53(1):261-6
pubmed: 22167095
Obes Surg. 2017 Jul;27(7):1835-1841
pubmed: 28138898
Public Health. 2016 Dec;141:32-41
pubmed: 27932013
Curr Eye Res. 2003 Sep;27(3):143-9
pubmed: 14562179
Exp Eye Res. 1991 Aug;53(2):151-6
pubmed: 1915670
Int J Obes (Lond). 2019 Sep;43(9):1675-1680
pubmed: 30518825
Indian J Ophthalmol. 2014 Nov;62(11):1060-1063
pubmed: 25494246
Sci Rep. 2018 Nov 16;8(1):16952
pubmed: 30446681
Retina. 2017 Jun;37(6):1120-1125
pubmed: 27632714
Surv Ophthalmol. 2007 Mar-Apr;52(2):180-95
pubmed: 17355856
Int J Obes (Lond). 2014 Sep;38(9):1241-7
pubmed: 24301134

Auteurs

Aniruddha Agarwal (A)

Department of Ophthalmology, Advanced Eye Center, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.

Arshiya Saini (A)

Department of Ophthalmology, Advanced Eye Center, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.

Sarakshi Mahajan (S)

School of Medicine, St Joseph Mercy Hospital, Oakland, Pontiac, Michigan, United States of America.

Rupesh Agrawal (R)

Department of Ophthalmology, National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore.

Carol Y Cheung (CY)

Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong.

Ashu Rastogi (A)

Department of Endocrinology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.

Rajesh Gupta (R)

Department of General Surgery, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.

Yu Meng Wang (YM)

Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong.

Michael Kwan (M)

Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong.

Vishali Gupta (V)

Department of Ophthalmology, Advanced Eye Center, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH